The Yaron Lab receives $2 Million NIH R01 grant to pursue disease mechanisms and therapeutic targets in psoriasis

Dr. Yaron has received a 5-year Stephen I. Katz R01 to investigate novel disease mechanisms and therapeutic targets in psoriasis. This work is a joint effort between ASU, Mayo Clinic, and Midwestern University and is led by Dr. Yaron as Principal Investigator. More details are available at: https://fullcircle.asu.edu/research/uncovering-psoriasiss-root-cause/